Financials
Financial year 2025
Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie from Wortegem-Petegem, company number BE0718953013, closed financial year 2025 with a result of € 507,767 after tax. For that financial year Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie recorded a gross margin of € 839,149 and equity of € 567,228. Compared with financial year 2024, the result moved from € 514,173 to € 507,767. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.
€ 567,228
▼ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 507,767
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 182,817
▼ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 521,940 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 14,200
▼ 2% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.1 million
▲ € 1.1 million vs 2024
€ 40,374 is repaid this year. At this pace the long-term loan is gone in ≈ 27 years.
€ 5,746
▲ 73% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 470,458 | € 707,498 | € 673,199 | € 839,149 | ▲ 25% |
| Profit after taxes | € 349,759 | € 521,767 | € 514,173 | € 507,767 | ▼ 1% |
| Equity | € 386,081 | € 542,228 | € 581,401 | € 567,228 | ▼ 2% |
| Total debts | € 25,984 | € 66,043 | € 12,335 | € 1,107,191 | ▲ € 1.1 million |
| Cash | € 328,538 | € 311,463 | € 218,938 | € 182,817 | ▼ 16% |
| Land & buildings | - | - | - | € 1,095,346 | |
| Retained profit | € 367,481 | € 523,628 | € 562,801 | € 548,628 | ▼ 3% |
| Dividend | € 274,118 | € 365,620 | € 475,000 | € 521,940 | ▲ 10% |
| Bank debt | € 12,385 | € 2,777 | € 16 | € 1,076,719 | ▲ € 1.1 million |
| Balance sheet total | € 412,064 | € 608,271 | € 593,736 | € 1,674,419 | ▲ 182% |
Key figures of Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie?
What happened at Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 507,767 (▼ 1% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
In short
From € 349,759 profit in 2022 to € 507,767 profit in 2025.
Paid € 618,358 in corporate taxes since 2022.
Best year ever: 2023, with € 521,767 profit.
Paid out € 1.6 million in dividends to the owners in total.
A new publication or filing at Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie? We notify you, reason included.
Follow Dr. Leysen - Ophtalmologie & Dr. Vereecke - EndocrinologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie are Gertjan VEREECKE and Laura LEYSEN. It owns 50% of Oogcentrum Oudenaarde itself.
Directors
According to the 2025 annual accounts
Gertjan VEREECKE
Director
Establishments
Establishment units
Physical locations of this company
Peerdekouterstraat (W.) 10
9790 Wortegem-Petegem
Bagattenstraat 53 box 501
9000 Gent
Active since 21 January 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0718.953.013
- VAT number
- BE 0718.953.013
- Registered office
- Peerdekouterstraat (W.) 10, 9790 Wortegem-Petegem
- Names & denominations
- Dr. Leysen - Ophtalmologie & Dr. Vereecke - Endocrinologie · Veledok
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 January 2019
- Peppol
- Active · Active since 3 Nov 2025
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van beroepsorganisaties